Trials / Unknown
UnknownNCT02163642
Role of Innate Immunity in Non-Cystic Fibrosis Bronchiectasis
Bronchial Infections in Patients With Non-Cystic Fibrosis (CF) Bronchiectasis; Role of Innate Lung Defense Mechanisms and Utility of an Electronic Nose for Its Diagnosis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that 1) the secretion of mucins, antimicrobial peptides and Toll-like receptors is altered in certain patients with non-CF bronchiectasis, which makes them more susceptible to be infected by potentially pathogenic bacteria (PPB); and 2) the electronic nose is able to detect patterns of specific Volatile Organic Compounds (VOC) for patients with non-CF bronchiectasis colonized by PPB.
Detailed description
Prospective, observational study, which will include 50 patients with non-CF bronchiectasis who will be followed for a period of 12 months. A follow up control will be performed every three months to all patients, consisting in medical record, lung function tests, blood and serum collection, sputum analysis and culture, and collection of exhaled air for analysis using an electronic nose. These tests will also be repeated whenever the patient has an exacerbation. At the beginning and end of the study, a high resolution chest CT will be performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cyranose® 320 | Detection of patterns of specific Volatile Organic Compounds in exhaled air |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2014-06-13
- Last updated
- 2016-09-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02163642. Inclusion in this directory is not an endorsement.